Does TRANDOLAPRIL Cause Product dose omission issue? 35 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Product dose omission issue have been filed in association with TRANDOLAPRIL (Trandolapril). This represents 5.7% of all adverse event reports for TRANDOLAPRIL.
35
Reports of Product dose omission issue with TRANDOLAPRIL
5.7%
of all TRANDOLAPRIL reports
0
Deaths
35
Hospitalizations
How Dangerous Is Product dose omission issue From TRANDOLAPRIL?
Of the 35 reports, 35 (100.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANDOLAPRIL. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does TRANDOLAPRIL Cause?
Dyspnoea (87)
Psychotic disorder (81)
Cough (76)
Fatigue (60)
Pneumonia (58)
Hypertension (57)
Asthma (56)
Hypotension (48)
Hallucination, auditory (46)
Paranoia (46)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TRANDOLAPRIL Alternatives Have Lower Product dose omission issue Risk?
TRANDOLAPRIL vs TRANDOLAPRIL\VERAPAMIL
TRANDOLAPRIL vs TRANEXAMIC ACID
TRANDOLAPRIL vs TRANYLCYPROMINE
TRANDOLAPRIL vs TRASTUZUMAB
TRANDOLAPRIL vs TRASTUZUMAB-ANNS